A Pharmacokinetic Study of Amphotericin B Lipid Complex Injection (Abelcet) in Patients with Definite or Probable Systemic Fungal Infections

This study describes a pharmacokinetic evaluation of amphotericin B (AMB) lipid complex injection (ABLC or Abelcet) in 17 patients with systemic fungal infection administered 5 mg/kg of body weight/day by infusion for 10 to 17 days. The results showed that AMB exhibited multiexponential disposition...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	Antimicrob Agents Chemother
Egile Nagusiak:	Adedoyin, Adedayo, Swenson, Christine E., Bolcsak, Lois E., Hellmann, Andrzej, Radowska, Danuta, Horwith, Gary, Janoff, Andrew S., Branch, Robert A.
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Microbiology (ASM) 2000
Gaiak:	Pharmacology
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90176/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10991885/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.10.2900-2902.2000
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!